-
cds.ahrq.gov/sites/default/files/workgroups/1176/CDS%20Connect%20Work%20Group%20May%202020%20Meeting%20Slides.pdf
May 01, 2020 - May 2020 CDS Connect Work Group Call
May 2020 CDS Connect Work Group Call
Agenda
Schedule Topic
• 3:00 – 3:02 • Roll Call, Michelle Lenox (MITRE)
• 3:02 – 3:05 • Review of the Agenda, Maria Michaels (CDC)
• 3:05 – 3:50 • CDS Artifact Review and Update across CDS Connect (MITRE)
• 3:50– 3:55 • What's New with …
-
cds.ahrq.gov/sites/default/files/workgroups/1131/CDS%20Connect%20Work%20Group%20March%202020%20Meeting%20Slides.pdf
March 01, 2020 - March 2020 CDS Connect Work Group Call
March 2020 CDS Connect Work Group Call
Agenda
Schedule Topic
• 3:00 – 3:02 • Roll Call, Michelle Lenox (MITRE)
• 3:02 – 3:10
• Review of the Agenda, Maria Michaels (CDC)
• Special Announcement
• 3:10 – 3:45 • Lessons Learned in CDS Usability: Mobilizing a Million Hearts (…
-
cds.ahrq.gov/sites/default/files/workgroups/27826/CDS_Connect_WG_Slides_July_2021.pdf
January 01, 2021 - July 2021 CDS Connect Work Group Call
July 2021 CDS Connect Work Group Call
Agenda
Schedule Topic
• 3:00 - 3:02 • Roll Call, Michelle Lenox (MITRE)
• 3:02 - 3:05 • Review of the Agenda, Maria Michaels (CDC)
• 3:05 - 3:50 • Lessons Learned with CDS Connect: CDS for Asthma Management Guidelines (NHLBI and Elimu …
-
cds.ahrq.gov/sites/default/files/workgroups/1261/CDS_Connect_WG_%20March2021_%20Summary.pdf
March 18, 2021 - CDS Connect Work Group Meeting Summary 3-18-2021
CDS (Clinical Decision Support) Connect Work Group
Meeting Summary
March 18, 2021
3:00 – 4:00 pm ET
Attendees: 49 people (43 attendees + 6 call-ins)
Organization Attendee Names
AHRQ Members Steve Bernstein, Roland Gamache, Ed Lomotan, Mary Nix, Mari…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation%20Guide_Abnormal%20Blood%20Glucose%20and%20Type%202%20DM_Part%20One,%20Screening_Final.pdf
September 01, 2019 - Glucose
abnormalities can be detected by measuring HbA1c, fasting plasma glucose (FPG) or with a
glucose
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/Implementation%20Guide_Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%20Risk_Final_0.docx
October 01, 2017 - CDS Connect Implementation Guide Draft
Agency for Healthcare Research and Quality (AHRQ)
Agency for Healthcare Research and Quality (AHRQ) Error! No text of specified style in document.
Implementation Guide
Longitudinal ASCVD Risk Assessment Tool for Updated 10-Year ASCVD Risk
Prepared for:
Agency for Healthcare Re…
-
cds.ahrq.gov/sites/default/files/workgroups/58631/CDS_Connect_WG_February_2022_Summary.pdf
January 01, 2022 - CDS Connect Work Group February 2022 Summary
Clinical Decision Support (CDS) Connect Work Group (WG)
Meeting Summary
February 17, 2022
3:00 – 4:00 pm ET
Attendees: 37 people, including 6 phone dial-ins
Organization Attendees
AHRQ Sponsors Mario Teran, Roland Gamache (2)
WG Members Alex Goel, Alison…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Abnormal_Glucose_Screening_Part%201_Intervention_Content.xlsx
January 01, 2012 - Example Intervention Text
Example Patient-Facing Intervention Text: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Screening for Abnormal Blood Glucos…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Abnormal_Glucose_Screening_Part%201_Intervention_Content_1.xlsx
January 01, 2012 - Example Intervention Text
Example Patient-Facing Intervention Text: Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Screening for Abnormal Blood Glucos…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final.pdf
September 01, 2019 - Statin Use for the Primary Prevention of CVD in Adults: Patient-Facing CDS Intervention
1
Implementation Guide
Statin Use for the Primary Prevention of CVD in
Adults: Patient-Facing CDS Intervention
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract N…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2024_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
January 01, 2024 - Example Intervention Text
Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact.
Imple…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/IG%20Abnormal%20Blood%20Glucose%20Type%202%20DM%20Screening.pdf
September 01, 2021 - Glucose
abnormalities can be detected by measuring HbA1c, fasting plasma glucose (FPG) or with a
glucose
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/508_2022_CDS_Connect_IG_T2DM_Part_One_Screening_final.pdf
January 01, 2022 - Glucose abnormalities can be
detected by measuring HbA1c, fasting plasma glucose (FPG) or with a glucose
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/Implementation_Guide_Prediabetes_and_Type_2_Diabetes_Part_One_Screening.pdf
September 01, 2022 - Glucose abnormalities can be
detected by measuring HbA1c, fasting plasma glucose (FPG) or with a glucose
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_CDS_Connect_IG_T2DM_Part_One_Screening_1.pdf
January 01, 2023 - Glucose abnormalities can be
detected by measuring HbA1c, fasting plasma glucose (FPG) or with a glucose
-
cds.ahrq.gov/cedar/AHRQ_CEDAR_Final_Project_Report_09_29_2022.pdf
January 01, 2022 - AHRQ CEDAR Final Project Report
AHRQ CEDAR
Final Project Report
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
Contract No. 75FCMC18D0047
Prepared by:
CMS Alliance to Modernize Healthcare (The Health FFRDC)
A Federally Funded Research and Development Cen…
-
cds.ahrq.gov/sites/default/files/workgroups/231/apr-2017-cholesterol-wg-notes.docx
January 01, 2017 - Cholesterol Management Work Group
Meeting Summary
Date
04/19/2017
Time
01:00 – 3:00 PM EST
AGENDA
· Welcome
· Brief Overview of Existing CDS Connect Artifacts
· Clarify Logic Details for USPTF-related Artifacts
· Discuss Best Approach for Transforming eCQM Specifications into CDS Logic
· Next Steps an…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Patient%20Facing%20CDS%20Intervention_Final_1.pdf
April 01, 2021 - Statin Use for the Primary Prevention of CVD in Adults: Patient-facing CDS Intervention (April 2021)
1
Implementation Guide
Statin Use for the Primary Prevention of CVD in
Adults: Patient-Facing CDS Intervention
Agency for Healthcare Research and Quality
5600 Fishers Lane
Rockville, MD 20857
www.ahrq.gov
…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2022_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
January 01, 2022 - Example Intervention Text
Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact.
Imple…
-
cds.ahrq.gov/sites/default/files/cds/artifact/1061/2023_Intervention_Content_Prediabetes_and_Type_2_Diabetes_Part_one_Screening.xlsx
January 01, 2023 - Example Intervention Text
Example Patient-Facing Intervention Text: Prediabetes and Type 2 Diabetes: Part 1, Screening
General Information
The example intervention text shown below is embedded in the Clinical Quality Language (CQL) files for the Prediabetes and Type 2 Diabetes Part One: Screening artifact.
Imple…